{
    "organizations": [],
    "uuid": "916209ac15c05e98961a4ee3f693aab559c81ec7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/celgene-results/celgene-posts-quarterly-loss-vs-year-ago-profit-idUSL4N1PK41O",
    "ord_in_thread": 0,
    "title": "Celgene posts quarterly loss vs. year-ago profit",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - Celgene Corp, which said it would buy Juno for $9 billion earlier this week, reported a quarterly loss on Thursday, hurt by a $1.21 billion income tax charge.\nThe U.S. biotechnology company posted a net loss of $81 million, or 10 cents per share, in the fourth quarter ended Dec. 31, from a profit of $429 million, or 53 cents per share, a year earlier.\nRevenue rose to $3.48 billion from $2.98 billion. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Martina Dâ€˜Couto)\n ",
    "published": "2018-01-25T20:41:00.000+02:00",
    "crawled": "2018-01-26T21:36:27.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "celgene",
        "corp",
        "said",
        "would",
        "buy",
        "juno",
        "billion",
        "earlier",
        "week",
        "reported",
        "quarterly",
        "loss",
        "thursday",
        "hurt",
        "billion",
        "income",
        "tax",
        "charge",
        "biotechnology",
        "company",
        "posted",
        "net",
        "loss",
        "million",
        "cent",
        "per",
        "share",
        "fourth",
        "quarter",
        "ended",
        "profit",
        "million",
        "cent",
        "per",
        "share",
        "year",
        "earlier",
        "revenue",
        "rose",
        "billion",
        "billion",
        "reporting",
        "akankshita",
        "mukhopadhyay",
        "bengaluru",
        "editing",
        "martina",
        "couto"
    ]
}